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Highly pathogenic avian influenza viruses (HPAIV) with reassorted NS segments from H5- and H7-
type avian virus strains placed in the genetic background of the A/FPV/Rostock/34 HPAIV (FPV; 
H7N1) were generated by reverse genetics. Virological characterizations demonstrated that the growth 
kinetics of the reassortant viruses differed from that of wild-type (wt) FPV and depended on whether 
cells were of mammalian or avian origin. Surprisingly, molecular analysis revealed that the different 
reassortant NS segments were not only responsible for alterations in the antiviral host response but 
also affected viral genome replication and transcription as well as nuclear ribonucleoprotein (RNP) 
export. RNP reconstitution experiments demonstrated that the effects on accumulation levels of viral 
RNA species were dependent on the specific NS segment as well as on the genetic background of the 
RNA-dependent RNA polymerase (RdRp). Beta interferon (IFN-β) expression and the induction of 
apoptosis were found to be inversely correlated with the magnitude of viral growth, while the NS allele, 
virus subtype, and nonstructural protein NS1 expression levels showed no correlation. Thus, these 
results demonstrate that the origin of the NS segment can have a dramatic effect on the replication 
efficiency and host range of HPAIV. Overall, our data suggest that the propagation of NS reassortant 
influenza viruses is affected at multiple steps of the viral life cycle as a result of the different effects of 
the NS1 protein on multiple viral and host functions. 
 
 
Since 1997, the emergence of a new H5N1 highly pathogenic avian influenza virus (HPAIV) has 
resulted in major losses to the poultry industry and caused over 460 human infections with 
approximately 60% mortality (12, 55). The virus first appeared in Asia but has now spread to many 
countries throughout Europe and Africa with the potential to cause a worldwide pandemic. H7-type 
HPAIV strains have caused outbreaks in Europe for many years and have resulted in some infections 
in humans, albeit with low mortality rates (18). With the rapid spread of H5N1 viruses to Europe, it is 
increasingly likely that H5-type viruses may reassort with H7-type HPAIV. We have previously shown 
that the NS segment of an H5N1 virus isolated in 1996 increased the replication and pathogenicity of 
an H7-type HPAIV (26) and were therefore interested in investigating the effect of other NS segments 
to determine how NS segments encoded by different H7 and H5 subtype viruses affect the virulence of 
an H7-type HPAIV. We were also interested in the effect of an NS segment from an H5N1 virus 
isolated after 1998, as it has previously been reported that the NS segment of such viruses cause 
enhanced replication in mammalian cells (52).  
 
Phylogenetic analysis of influenza A virus NS segments shows that they can be classified into two 
groups: allele A and allele B (39). NS segments of human, swine, most equine, and some avian 
influenza viruses (IV) belong to allele A, while NS segments of one equine and other avian IV are 
grouped into allele B (24, 50). The only example of an allele B NS segment from a mammalian IV, 
  
A/Equine/Jilin/89, originated in China and caused severe disease and high mortality in horses. The 
virus appeared to have crossed to horses from an avian source, since all eight segments appeared to 
be avian-like (15). Although a previous study showed that an HPAIV (A/FPV/Rostock/34 [FPV; H7N1; 
allele A] virus) which received allele B NS segments resulted in attenuated variants in squirrel 
monkeys (51), we have shown that a reassortant of this strictly avian HPAIV carrying the allele B NS 
segment of A/Goose/Guangdong/1/96 (GD; H5N1) virus was more virulent than the wild-type H7N1 
virus and can productively infect mice (26). A/Goose/Guangdong/1/96 was the source of the 
hemagglutinin (HA) and neuraminidase (NA) gene segments in the A/HongKong/483/97 (HK97) virus, 
which caused the first cluster of confirmed human cases of avian influenza infection in the world (4). 
The original GD virus itself has become established in geese and formed a distinct lineage in southern 
China (5, 21). Here, we aimed to examine the effect of another allele B NS segment of a virus isolated 
after 1998, A/Mallard/NL/12/2000 (Ma; H7N3) virus, as well as an allele A NS segment of a recent 
H5N1-type virus, A/Vietnam/1203/2004 (VN; H5N1) virus, on the replication and virulence of the H7N1 
HPAIV strain FPV. VN is a human isolate from 2004 (21) and therefore emerged more recently than 
the GD H5N1 strain.  
 
The NS segment encodes the nonstructural protein NS1, which is translated from unspliced mRNA, 
and the nuclear export protein NS2/NEP, which is translated from spliced mRNA transcripts. The NS1 
protein has been shown to be   major pathogenicity factor. As such, it can impair host innate and 
adaptive immunity in a number of ways. It can bind to double-stranded RNA (dsRNA), thereby 
suppressing the activation of double-stranded RNA-activated protein kinase (PKR), a known stimulator 
of type I interferon (IFN) (3). Furthermore, it can inhibit retinoic acid-inducible gene I (RIG-I)-mediated 
induction of IFN by (i) binding to RIG-I and preventing it from binding to single-stranded RNA (ssRNA) 
bearing 5’ phosphates (32), (ii) forming an NS1/RIGI–RNA complex (45), or (iii) interacting with the 
ubiquitin ligase tripartite motif 25 (TRIM25) and inhibiting TRIM25-mediated RIG-I caspase recruitment 
domain (CARD) ubiquitination (11). Another way NS1 impairs the production of IFN is by preventing 
the activation of transcription factors, such as activating transcription factor 2 (ATF-2)/c-Jun, NF-KB, 
and interferon regulatory factor 3 (IRF-3), IRF-5, and IRF-7, all of which stimulate IFN production (13, 
19). By forming an inhibitory complex with NXF1/TAP, p15/NXT, Rae1/mrnp41, and E1B-AP5, which 
are important factors in the mRNA export machinery, NS1 decreases cellular mRNA transport in order 
to render cells highly permissive to IV replication (48). NS1 can also inhibit the 3’-end processing of 
cellular premRNAs (including IFN pre-mRNA) through interaction with the cellular proteins CPSF30 
(53) and PABII (6). A further NS1 activity is the direct blockade of the function of 2’-5’- oligoadenylate 
synthetase (OAS) (33) and PKR (3), important regulators of translation that can induce IFN production 
and the host apoptotic response.  
 
Additionally, many studies have highlighted the importance of the interaction between the 
ribonucleoprotein (RNP) complex and NS1 for viral replication (10, 20, 28, 34). The NS1 protein was 
shown to interact with the RNP complex in vivo (28), and truncated NS1 affected production of viral 
RNA (vRNA) but not of cRNA and mRNA in infected Madin-Darby canine kidney (MDCK) cells, 
implicating NS1 in the regulation of replication (10). The influenza A virus NS1 protein 
was also found to regulate the time course of viral RNA synthesis during infection, as a mutant virus 
with two amino acid changes at positions 123 and 124 deregulated the normal time course of viral 
RNA synthesis (34). The influenza A virus polymerase is an integral component of the CPSF30-NS1A 
complex in infected cells (20), and the NS1 protein of influenza B virus is thought to form a complex 
with PKR and the RNP complex (8). The NS2/NEP protein interacts with the viral M1 protein and 
mediates the export of viral RNPs (vRNPs) from the nucleus to the cytoplasm (40) and has also been 
shown to play a role in the regulation of viral replication and transcription (46). However, a direct 
interaction between NS2/NEP and the viral polymerase complex has not been demonstrated.  
 
It is therefore evident that both the NS1 and NS2/NEP proteins play important roles in viral 
pathogenicity and replication. However, it is still unclear how they act on the viral RNP complex and 
which mechanisms are involved. In this study, a series of recombinant A/FPV/Rostock/34 (FPV; 
H7N1) viruses with NS segments from FPV, A/Goose/Guangdong/1/96 (GD; H5N1) virus, 
A/Vietnam/1203/2004 (VN; H5N1) virus, and A/Mallard/NL/12/2000 (Ma; H7N3) virus were generated 
by reverse genetics. We show that NS segments from different H5- and H7-type HPAIV can alter the 
replication efficiency of FPV in mammalian and avian cells. Furthermore, we found that the effect of 
the NS segments on virus titers was not dependent on the NS allele. The results also indicate that the 
H5-type IV NS segment from a virus that emerged after 1998 did not increase virus replication of the 
H7-type FPV in mammalian cells. The exchange of NS segments did not only change the host antiviral 
response, including the type I interferon response and apoptosis, but also altered the production of 
viral RNA species and viral genome transport. In summary, the propagation of NS reassortant 
  
influenza viruses is affected at multiple steps of the viral life cycle as a result of the effects of the NS1 
protein on multiple viral and host functions. 
 
 
Materials and Methods 
 
Cells, virus infection, titration, and HA assay. Human embryonic kidney (HEK) 293T cells 
(constitutively expressing the SV40 large T antigen), A549 cells (human alveolar epithelial cells), and 
MDCK cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 
10% fetal calf serum (FCS) and antibiotics (100 U ml-1 penicillin and 0.1 mg ml-1 streptomycin) at 37°C. 
QT6 (quail fibroblast) cells were maintained in Ham’s F-10 medium containing 1% L-glutamine, 
supplemented with 8% heat-inactivated FCS, 2% chicken serum, 2% tryptose phosphate broth, and 
streptomycin/penicillin. LMH (chicken hepatocellular carcinoma) cells were maintained in RPMI 1640 
medium containing 1% L-glutamine supplemented with 8% heat-inactivated FCS, 2% chicken serum, 
and streptomycin/penicillin. The cells were incubated at 37°C with 5% CO2 and 95% humidity.  
 
Confluent cells were washed with phosphate-buffered saline (PBS) and infected with the various 
viruses at the indicated multiplicity of infection in PBS-BA (PBS containing 0.2% bovine serum albumin 
[BSA], 1 mM MgCl2, 0.9 mM CaCl2, 100Uml-1 penicillin, and 0.1 mg ml-1 streptomycin) for 1 h at room 
temperature (RT). The inoculum was aspirated, and the cells were incubated with DMEM-BA medium 
containing 0.2% BSA and antibiotics at 37°C. Virus titer was determined via focus assay as described 
earlier (26). For the phenotype experiments, the diameters of focus plaques were measured, and the 
distribution curve was drawn with the statistics software Origin 8.0. The hemagglutination assay was 
performed according to standard procedures using 1.5% chicken red blood cells. The results represent 
the averages from three independent experiments. 
 
Plasmid construction. In order to clone the polymerase and NP genes of GD and FPV into 
pcDNA3.0 (FPV PB1, FPV PB22, and FPV PA; GD PB1, and GD PB2) and pcDNA3.1 (FPV NP; GD 
PA and GD NP) vectors, the PB2, PB1, and PA genes of FPV and the PB1 and PB2 genes of GD 
were PCR amplified from the corresponding polymerase I (Pol I)-driven plasmids using the 
oligonucleotides described in Table 1. The PCR products were amplified, purified, and cloned into a 
TA cloning vector (Invitrogen), and after being sequenced they were subcloned into pcDNA3.0 
vectors.  
 
The pHMG-PB1, -PB2, -PA, and -NP plasmids, encoding the polymerase and NP proteins of A/Puerto 
Rico/8/34 (PR8; H1N1) virus under the control of a hydroxymethylglutaryl-coenzyme A reductase 
promoter, have been described previously (41), as have the pPolI-PB2, -PB1, -PA, -HA, -NP, -NA, -M, 
and –NS plasmids, encoding the viral gene sequences of A/FPV/Rostock/34 virus cloned 
between the human Pol I promoter and mouse Pol I terminator (26). The pBD-NS plasmid encoding 
the NS gene of A/Goose/Guangdong/1/96 has been described before (26) for the pHW2000-VN-NS 
plasmids encoding the A/Vietnam/1203/2004 NS segments, the corresponding viral RNA RT-PCR 
product was cloned into pHW2000, and the pPolI-NS plasmid encoding A/Mallard/NL/12/2000 NS 
vRNA was kindly provided by K. Saksela (Helsinki, Finland).  
 
The expression plasmids pcDNA3.0-GD-NS1 and pcDNA3.0-FPV-NS1, encoding the NS1 proteins of 
the influenza virus strains GD and FPV under the control of a cytomegalovirus (CMV) promoter, have 
been described before (26). VN NS1, Ma NS1, FPV NS2, GD NS2, VN NS2, and Ma NS2 were PCR 
amplified with primers (shown in Table 1) and cloned into pcDNA3.1 by using the pcDNA 3.1 
directional TOPO expression kit (Invitrogen). All plasmid sequences were confirmed by sequencing. 
 
RNP reconstitution assay. To analyze viral polymerase expression activity via CAT assay, 293T 
cells at 70 to 80% confluence were transfected with Lipofectamine 2000 (Invitrogen) with four plasmids 
encoding the PB1, PB2, PA, and NP proteins from FPV, GD, or PR8 (DNA mixture, 1.2 μg in the ratio 
of 1:1:1:2) and pPolI-CAT-RT (2.0 μg) (41) and with empty vector (4.0 μg) or pcDNA3.0-NS1 (4.0 μg) 
encoding the NS1 gene of FPV, GD, or PR8. At 48 h posttransfection, cell extracts were prepared and 
tested for chloramphenicol acetyltransferase (CAT) activity (1:10 dilution). CAT assay was described 
previously (41). To analyze viral polymerase replication and transcription activity, 293T cells were 
transfected in suspension using 10 μl Lipofectamine 2000 (Invitrogen) and 1 μg of each of the relevant 
plasmids in 1.5 ml of minimal essential medium (MEM) with 10% fetal calf serum. Cells were 
harvested 48 h posttransfection.  
 
  
Generation of wild-type FPV and reassortant viruses. Transfection and virus rescue of wild-type 
(wt) FPV and NS reassortants were performed as previously described (26). To generate the 
reassortant viruses carrying different NS segments (GD NS, VN NS, and Ma NS), the pPolI-NS FPV 
plasmid was replaced by the pPolI-NS plasmids of GD, VN, or Ma. At 48 h posttransfection, the 
supernatants were harvested and used to infect confluent MDCK cells in 6-cmdiameter dishes to 
amplify the progeny viruses. After three rounds of plaque purification, the reassortant viruses were 
confirmed by restriction enzyme digestion of reverse transcription (RT)-PCR products obtained from 
the NS vRNA. Additionally, the NS, HA, NA, and PB2 segments from different reassortant viruses also 
were amplified by RT-PCR and sequenced by GATC Biotech. The purified viruses were then amplified 
and titrated on MDCK cells by focus assay and stored at -70°C. The generation of all viruses was 
carried out using biosafety level 3 procedures. 
 
In-cell Western blotting. In-cell Western blotting using MDCK cells was performed as previously 
described (26). Briefly, to detect NS1, NP, and extracellular signal-regulated kinase 2 (ERK2; loading 
control), cells were incubated with a primary antibody, which was either polyclonal rabbit anti-NS1 
serum (antiglutathione S-transferase (GST)-NS1 9101 at a dilution of 1:1,000), mouse anti-NP 
monoclonal antibody (MAb) (1:5,000; Abcam), mouse anti-ERK2 MAb (1:100; Santa Cruz), or 
polyclonal rabbit anti-ERK2 (1:100; Santa Cruz) serum. Thereafter, cells were washed and incubated 
in the dark with a second antibody (goat anti-rabbit IRDye 680 or goat anti-mouse IRDye 800 CW, 
Licor). Finally, plates were washed with PBS, dried, and analyzed using the Odyssey infrared imaging 
system and application software package (Licor). For each time point, six wells were analyzed. 
 
Immunofluorescence. Confocal laser scanning analysis was performed as previouslydescribed (26). 
Briefly, MDCK cells grown on glass coverslips were infected and incubated for the indicated time 
points in media. Fixed cells were washed and incubated with mouse anti-NP monoclonal antibody 
(1:200 in PBS-3% bovine serum albumin; Biodesign International; clone F 1331) or mouse anti-GST-
NS1 polyclonal antibody (1:1,000 in PBS-3% bovine serum albumin). Cells were then washed and 
incubated with TexasRed-labeled goat anti-mouse antibody (Sigma). After further washes, cells were 
incubated with DAPI (4’,6-diamidino-2-phenylindole; 10 mg ml-1 in PBS-3% bovine serum albumin; 
Roth). Finally, cells were washed and fixed in Mowiol (Sigma-Aldrich) in glycerol and H2O 
supplemented with 2.5% DABCO [1,4-diaza-bicyclo(2.2.2)octane] (Merck). Fluorescence was 
visualized using a TCSSP5 confocal laser-scanning microscope (Leica). 
 
RNA isolation and primer extension assay. Confluent MDCK cells in 35-mm dishes were infected 
with the different reassortant viruses at a multiplicity of infection (MOI) of 1, and total cellular RNA was 
extracted with Trizol reagent (Invitrogen) at 2 h, 4 h, 6 h, and 8 h postinfection (p.i.). Primer extension 
was performed using 10 μl RNA (approximately 5 μg) mixed with an excess of DANN primer 
(approximately 105 cpm), labeled at the 5’ end with [γ-32P]ATP, in 6 μl of water and denatured by 
heating at 95°C for 3 min. The mixture was cooled on ice and 100 units of SuperScript III reverse 
transcriptase (Invitrogen) and ist reaction buffer were added before further incubation at 50°C for 60 
min. The gene-specific DNA primers used were NA vRNA (5’-GTAGCAATAACTGATTGGTCG-3’; 
expected size, 130 nucleotides [nt]), NA mRNA and cRNA (5’-
GCGCAAGCTTCATGAGATTATGTTTCC-3’; expected size for cRNA, 160 nt; expected size for 
mRNA, approximately 170 nt), NP vRNA (ATGATGGA GAGTGCCAGACC 3’; expected size, 181 nt), 
and NP mRNA and cRNA (5’ACCATTCTCCCAACAGATGC 3’; expected size for cRNA, 121 nt; 
expected size for mRNA, approximately 135 nt). A primer for cellular 5S rRNA (5’-
TCCCAGGCGGTCTCCCATCC-3’) was used as an internal control. Transcription products were 
analyzed on 6% polyacrylamide gels containing 7 M urea in Tris-borate-EDTA (TBE) buffer and were 
detected by autoradiography. Quantification was performed using Typhoon 9200 (GE Healthcare), and 
the values were converted to mean percentages of activity, compared to the wild type, and presented 
in a graphical format using Excel (Microsoft). The significance of the data was tested using a two-tailed 
one-sample t test. 
 
IFN-β ELISA. Beta interferon (IFN-β) concentrations were assessed using a human IFN-β enzyme-
linked immunosorbent assay (ELISA) kit (Fujirebio) according to the manufacturer’s protocol. Briefly, 
confluent A549 cells in 3.5-cm dishes were infected with the different reassortant viruses at an MOI of 
0.01, and at 24 h p.i., 36 h p.i., and 48 h p.i., 100 μl of supernatant and standards were added to 96-
well plates coated with human IFN-β IgG Fab fragments and incubated for 1 h with shaking at RT. 
After 2 washes with washing solution, the human horseradish peroxidase (HRP)-labeled IFN-β 
antibody was added and incubated for 1 h with shaking at RT. After 3 washes, the substrate solution 
was added to develop the color, followed by the stop solution (0.5MH2SO4), and the optical density at 
450 nm (OD450) was measured. 
  
Apoptosis. The terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling 
(TUNEL) assay was done using an in situ cell death detection kit (fluorescein) (Roche). Briefly, MDCK 
cells grown on glass coverslips were infected and incubated in medium as described above, washed 
with PBS at 10 h p.i., and fixed with 4% paraformaldehyde (PFA) in PBS (pH 7.4) overnight. The 
samples were washed twice with PBS and permeabilized with 1% Triton X-100 in 0.1% sodium citrate 
on ice for 20 min. Cells were washed and incubated with 50 μl reaction mixture or the no-enzyme 
control in 50 μl label solution for 1 h in the dark. After 3 washes with PBS, cells were washed twice 
and were fixed in Mowiol (Sigma-Aldrich) in glycerol and H2O supplemented with 2.5% DABCO 
(Merck). Fluorescence was visualized using a TCS-SP5 confocal laser-scanning microscope (Leica). 
 
Relative caspase3 activity was measured with a caspase3 colorimetric assay kit (GenScript). MDCK 
cells were infected with the different recombinant viruses at an MOI of 1. At 8 h p.i., the cells were 
harvested and lysed. Cell lysate (150 μg), reaction buffer, and caspase3 substrate (200 μM labeled 
substrate DEVD-pNA) were mixed according to the manufacturer’s description and used to measure 






Reassortment of the NS segment can change the plaque phenotype, the infectious titer, and 
the HA titer of reassortant FPV viruses. By reverse genetics, we generated the reassortants FPV 
NS GD, FPV NS Ma, and FPV NS VN, carrying the NS segment of A/Goose/Guangdong/16 (GD; 
H5N1), A/Mallard/NL/12/2000 (Ma; H7N3), and A/Vietnam/1203/2004 (VN; H5N1) viruses, 
respectively, in the genetic background of A/FPV/Rostock/34 (FPV; H7N1). In order to investigate 
whether the different NS segments altered the replication ability of the wt FPV virus, the plaque sizes 
of the different viruses were analyzed using MDCK cells (Fig. 1A), and the determined plaque 
diameters are represented as distribution curves in Fig. 1B. The reassortant virus FPV NS Ma 
produced plaques similar in size to those produced by wt FPV, while those of FPV NS VN were much 
smaller and those of FPV NS GD were much bigger than those of wt FPV. This indicates that the FPV 
NS GD virus has a propagation advantage in MDCK cells than do the other three viruses, confirming 
previous finding (26). In contrast, the FPV NS VN virus seems to replicate less efficiently in MDCK 
cells than do the other viruses.  
 
Viral growth curves and the HA titers of the different viruses in MDCK cells were also determined (Fig. 
1C). This analysis demonstrated that FPV NS GD replicates to higher titers than wt FPV, most 
conclusively at 36 h p.i., while FPV NS VN and FPV NS Ma replicated to lower titers (Fig. 1C, lines). 
This shows that the NS segments of both H7- and H5-type HPAIV can affect the virus replication 
efficiency of FPV in MDCK cells and corresponds to the results obtained from the plaque phenotypes. 
Although both the Ma and GD NS segments are grouped in allele B, the differences in the infectious 
titers between these two viruses indicate that the effects of the NS gene on virus replication efficiency 
are not dependent simply on the allele type. In addition, these results suggest that not all H5-sourced 
NS segments necessarily increase the H7-type HPAIV infectious titer, as both the GD and VN NS 
segments are from H5N1 viruses and only the FPV NS GD virus had an increased titer.  
 
In order to determine whether the NS segments could affect the propagation of FPV in host cells of 
different origins, virus growth curves in two other mammalian cell lines and two avian cell lines were 
investigated (see Fig. S1 in the supplemental material). Results similar to those found in MDCK cells 
(Fig. 1C) were obtained for the mammalian A549 and 293T cell lines. However, in avian LMH and QT6 
cells, the NS reassortants showed different growth curves. The wt FPV, FPV NS GD, and FPV NS Ma 
viruses had similar titers between 24 h and 36 h p.i., while FPV NS VN had a significantly lower titer 
(see Fig. S1 in the supplemental material). Even though the parental strain (A/VN/1203/2004) is 
known to replicate well in chickens, ducks, mice, ferrets, and humans (27), the reassortant FPV NS 
VN virus appears to be attenuated in the mammalian and avian cell lines tested. In contrast, the FPV 
NS Ma and wt FPV viruses replicate as efficiently as FPV NS GD in avian cells but less well in the 
mammalian cells employed in our study. It is therefore possible that NS segment reassortment can 
affect virus propagation in cell lines of different host origin.  
 
Furthermore, the HA titers of the viruses differed from the infectious virus titers (Fig. 1C, bars), which 
may indicate that different NS segments can affect the formation of virus particles and change the ratio 
of defective particles to infectious particles. For example, at 48 h p.i., FPV NS VN has the highest HA 
  
titer of the reassortant viruses, equivalent to that of wt FPV; however, this virus has a much lower 
infectious titer than that of the wt virus in MDCK cells (Fig. 1C). FPV NS VN also has a low titer in the 
other mammalian and avian cell lines tested, while it produces HA titers higher than or similar to those 
of the other reassortant viruses (see Fig. S1 in the supplemental material), suggesting that this virus 
produces large numbers of noninfectious particles. 
 
NS segment reassortment can affect viral genome replication and transcription. In order to 
analyze whether NS segment exchange affects the viral genome replication and transcription, MDCK 
cells were infected with the different viruses, RNA was harvested at various time points p.i., and NA 
segment-specific primer extensions were performed (Fig. 2). The results showed that NS segment 
reassortment altered the relative accumulation levels of viral RNA species for the different viruses. We 
show that the FPV NS GD virus had increased accumulation of mRNA, cRNA, and vRNA compared to 
that  of the wt FPV, FPV NS Ma, and FPV NS VN viruses (Fig. 2B, C, D). Interestingly, the FPV NS 
Ma virus also produced higher levels of mRNA compared to the wt FPV and VN reassortants and 
showed a difference in the kinetics of mRNA accumulation. mRNA levels for FPV NS Ma peaked at 6 
h p.i., while for the other three viruses they peaked at 4 h p.i. (Fig. 2B). Similar levels of accumulation 
of cRNA and vRNA were found for all of the viruses, with the exception of FPV NS GD (Fig. 2C and 
D). In order to determine whether the effects on replication and transcription were segment specific, 
we also analyzed viral RNAs derived from the NP segment. The results obtained (data not shown) 
show relative RNA accumulation levels similar to those obtained for the NA gene, indicating that the 
effect of NS segment exchange on the production of RNA species is not segment specific. Overall, 
these results suggest that the proteins expressed from the NS segment play a role in the regulation of 
viral replication and transcription.  
 
Expression of the NS1 and NS2/NEP proteins affects the accumulation of viral RNAs in an RNP 
reconstitution assay. 
Having shown that NS segment exchange can affect the transcription and replication of the viral RNA, 
we set out to further investigate the role of individually expressed NS1 and NS2/NEP proteins on these 
processes. An RNP reconstitution assay was employed in which the four different NS1 or NS2/NEP 
proteins were individually coexpressed with the FPV polymerase and NP proteins and a viral RNA 
template (41). The results show that the transient expression of both NS1 and NS2/NEP proteins 
affected the accumulation of viral RNAs (Fig. 3). Expression of all NS2/NEP proteins resulted in an 
increase in cRNA levels compared to that of the negative control, consistent with a previous report 
(46) (Fig. 3B). However, the NS2/NEP proteins of GD, Ma, and VN did not produce significant 
changes in the accumulation of viral RNAs compared to the FPV NS2/NEP proteins, suggesting that 
this protein is not responsible for the differences in transcription and replication between the 
reassortant viruses. This is also supported by the results of a transfection/infection experiment (see 
Fig. S2 in the supplemental material), where we analyzed virus replication in MDCK cells transiently 
expressing the different NS2/NEP proteins after superinfection with wt FPV. Here, no specific effect by 
different NS2/NEP proteins on the virus titer was observed. Expression of all NS1 proteins resulted in 
a decrease in the accumulation levels of all viral RNAs compared to the levels in the negative control 
(Fig. 3C). Compared to FPV NS1, GD NS1 downregulated the accumulation of mRNA, while the Ma 
and VN NS1 proteins had little or no effect. The differential effect of the GD NS1 protein on the 
accumulation levels of viral mRNA may indicate a role for NS1 in viral transcription and replication.  
 
It has been reported previously that the NS1 protein can inhibit cellular mRNA processing through an 
interaction with CPSF30 (22, 36, 53) and PABII (6). To address the possibility that viral polymerase 
proteins and NP in the RNP reconstitution assay expressed from Pol II promoter-driven constructs 
were affected by NS1 protein expression, we transfected cells with a Pol II-driven reporter (pcDNA3.0-
CAT) and an NS1expression construct (pcDNA-GD-NS1). GD NS1 protein expression did not affect 
CAT protein expression (Fig. 3D), and therefore we conclude that viral protein expression from Pol II 
promoter-driven plasmids in the RNP reconstitution assay is unlikely to be affected by the NS1 protein. 
 
To investigate the effect of different NS1 proteins on polymerase function, plasmids expressing 
polymerase proteins and nucleoprotein from either FPV, GD, or A/Puerto Rico/8/34 (PR8) viruses, 
together with a CAT reporter vector (41) and plasmids expressing different NS1 proteins (FPV,GD, 
and PR8), were transfected into 293T cells. We found that the FPV and GD NS1 proteins decreased 
the reporter gene expression in all three virus systems (see Fig. S3 in the supplemental material). 
These results are in agreement with the observation from the RNP reconstitution assay (Fig. 3B) that 
the various NS1 proteins can decrease the accumulation of all viral RNA products. Surprisingly, the 
PR8 NS1 protein enhanced CAT expression in the homologous PR8 system but not in the FPV or GD 
systems (see Fig. S3 in the supplemental material). Taken together, these data suggest that the NS1 
  
proteins may affect the RNP complex and regulate transcription and replication without the help of 
other viral proteins. 
 
NS1 protein localization does not correlate with infectious viral titer. NS1 contains two nuclear 
localization signals and one nuclear export signal, which are responsible for the transport of the 
protein between the nucleus and cytoplasm. The NS1 protein can therefore be present in the nucleus, 
the cytoplasm, or both (14, 43). Our amino acid sequence comparison (see Fig. S4 in the 
supplemental material) showed that the sequence of both the NLS1 (34 to 39 amino acids [aa]) and 
NLS2 (216 to 220 aa) are conserved between the four NS1 proteins; however, the nuclear export 
sequence (NES) (138 to 147 aa) differs at three amino acid positions between the allele A and B NS1 
proteins. Therefore, we investigated the localization of the NS1 proteins of the different reassortant 
viruses in both infected and transfected MDCK cells. At all time points of infection, it was found that 
FPV NS1 was predominantly nuclear, GD NS1 and Ma NS1 were predominantly cytoplasmic, and VN 
NS1 showed a cytoplasmic and nuclear localization (Fig. 4A). There was therefore no correlation 
between the infectious titer of the reassortant viruses and NS1 localization during infection. 
Interestingly, when NS1 localization was investigated in transfected MDCK cells after 24 h, NS1 
proteins of all viruses were located exclusively in the nucleus (Fig. 4B). 
 
NS segment exchange alters RNP export. Efficient nuclear export of RNPs is important for the 
production of infectious virus (42). In order to investigate whether the NS segment exchange affected 
viral RNP export patterns, NP localization was analyzed by immunofluorescence microscopy (Fig. 5A). 
At 8 h p.i., most of the NP of wt FPV was located in the cytoplasm, as was that of FPV NS GD, while 
FPV NS Ma and FPV NS VN showed a more nuclear localization. These results indicate that NS 
segment exchange can alter RNP export and suggest a correlation between rapid RNP export and 
higher infectious virus titers.  
 
It has previously been shown that virus-induced activation of the Raf/MEK/ERK (mitogen-activated 
protein kinase [MAPK]) signal transduction cascade is an essential prerequisite for efficient nuclear 
RNP export (42). Membrane accumulation of the viral hemagglutinin (HA) glycoprotein in lipid-raft 
domains seems to be an important trigger that coordinates this signal-induction event with packaging 
of new RNPs into progeny virions (29). Induction or inhibition of the cascade will increase or reduce 
progeny virus titers, respectively (25, 30, 42). Therefore, we investigated the extent to which the 
viruses activated the MAPK cascade by detection of activated ERK (P-ERK) (Fig. 5B and 5C). The 
highest level of phosphorylated ERK was detected for the FPV NS GD virus, followed by that detected 
for wt FPV, with lower levels detected for FPV NS Ma and FPV NS VN. These results correlate with 
the finding that the RNPs of the wt FPV and GD NS viruses are transported more efficiently than those 
of the FPV NS Ma and VN viruses. 
 
NS segment exchange affects IFN-β levels and apoptosis levels. In order to test the ability of the 
different NS1 proteins to counteract the host innate immune response to support virus propagation, 
IFN-β levels in A549 cells infected with reassortant viruses at an MOI of 0.01 at various time points (24 
h, 36 h, and 48 h p.i.) were measured by ELISA. We found that FPV NS VN induced the highest IFN-β 
response at all time points compared to that of the other three viruses, and FPV induced the second-
highest response at 24 and 36 h p.i. (Fig. 6). When comparing these results to the infectious titers of 
the various viruses, it can be concluded that in general higher IFN-β levels correlate with lower 
infectious titers of the reassortant viruses.  
 
During the course of our experiments we observed that the FPV NS VN virus appeared to show a 
different cytopathic effect (CPE) in MDCK cells than the wt FPV, FPV NS GD, and FPV NS Ma 
viruses. Cells infected with FPV NS VN rounded up but did not detach from the dishes, while infection 
with the other three viruses resulted in the cells becoming detached. We hypothesized that the FPV 
NS VN virus might induce different levels of apoptosis compared to the other viruses. In order to 
determine the extent of apoptosis induced in cells infected with the different viruses, a TUNEL assay 
was performed in which MDCK cells were infected and examined by confocal microscopy (7). The 
number of apoptotic cells was counted in five random viewing fields, and the results were represented 
as a graph (Fig. 7). We observed that the FPV NS VN virus induced the highest levels of apoptosis, 
followed by FPV NS Ma, wt FPV, and FPV NS GD (Fig. 7B). The additional determination of caspase3 
activity at 8 h p.i. (Fig. 7 C) confirmed these results. Reassortant viruses containing different NS 
segments therefore differ in their abilities to induce cell death. When the extent of apoptosis is 
compared to the infectious titers of the various viruses, it can be concluded that the higher levels of 




In this report, we showed that replacement of the NS segment of the A/FPV/Rostock/34 (H7N1) 
influenza virus with NS segments from a variety of other H5- and H7-type viruses resulted in changes 
in the viral characteristics in mammalian and avian cell culture. In order to elucidate how NS segment 
reassortment altered virus propagation, multiple aspects of the interaction between the reassortant 
viruses and the host were examined.  
 
We show that the FPV NS GD virus, which has an allele B NS segment, replicated more efficiently 
than the wt FPV virus (allele A) in mammalian cell culture systems. This result and the previous finding 
that the FPV NS GD virus is able to replicate in mice in contrast to wt FPV (26) suggest that the GD 
NS segment may help the virus cross the host barrier to mammals. However, the general effect of NS 
exchange on the replication efficiency is independent of the genetic NS group, as the second virus 
with an allele B NS segment, FPV NS Ma, had a lower replication titer than wt FPV. Also, the effect of 
NS gene exchange on the propagation of recombinant viruses was not caused by differences in the 
NS1 protein expression levels (see Fig. S5 in the supplemental material), as the different properties of 
the recombinant viruses do not correlate with the different NS1 expression levels. Similar results were 
obtained for the NP expression levels (data not shown).  
 
We also addressed the question of whether H5-sourced NS segments, particularly those from viruses 
that emerged after 1998, increased viral growth of an H7-type HPAIV in mammalian cells. In a 
previous study by Twu et al. (52), a series of reassortants of the human A/Udorn/72 (Ud; H3N2) virus 
carrying different NS segments were generated. It was shown that the reassortant with the NS 
segment of A/Hong Kong/483/97 (HK97; H5N1) virus replicated less efficiently, while the reassortant 
with the A/Vietnam/1203/04 (VN04; H5N1) virus NS segment replicated as efficiently as that of wt Ud. 
It was concluded that H5N1 virus NS genes selected after 1998 seemed to enhance viral replication in 
mammalian cells. However, in our study, we observed that the NS segment from the VN virus isolated 
in 2004 decreased the replication of the reassortant avian H7-type virus (FPV), while the NS segment 
from the GD virus, isolated in 1996, enhanced FPV replication. This shows that H5-sourced NS 
segments do not necessarily increase the replication of avian IV and the year of emergence does not 
appear to play a major role. Furthermore, it is possible that the same NS segment may have different 
effects on virus replication depending on the specific genetic background.  
 
The replication differences of the reassortant viruses in mammalian and avian cells (see Fig. S1 in the 
supplemental material) suggest that the effect of NS segments on viral propagation also depends on 
specific host factors. In avian cells, wt FPV, FPV NS GD, and FPV NS Ma had similar titers but FPV 
NS VN had a significantly (2 logs) lower titer, whereas in mammalian cells FPV NS GD replicated to 
titers of almost 1 log higher than that of wt FPV and 2 logs higher than that of FPV NS Ma. The NS 
segments of GD, FPV, and Ma originated from avian viruses, and therefore it is tempting to speculate 
that they all could have a replication advantage in avian cells. In this context, it should be noted that in 
a previous study, the NS segment of the 1918 IV (H1N1) was set in the genetic background of 
A/WSN/33 (H1N1). The virus replicated well in tissue culture (MDCK cells) but was attenuated in mice 
compared with the control viruses (2). It was suggested that the attenuation in mice may be related to 
the human origin of the 1918 NS1 gene and that interaction of the NS1 protein with host-cell factors 
plays a significant role in viral pathogenesis. Taken together, for the effects exerted by the NS 
segment exchange, it seems to be relevant from which host the donor strain was isolated and in which 
host the recipient is tested.  
 
IV with C-terminally truncated forms of NS1 have previously been found to produce less vRNA than 
wild-type viruses, suggesting that the NS1 protein is involved in viral replication (10). In our report, the 
C terminus of the VN NS1 is truncated by 10 aa, but the results in Fig. 2 show similar vRNA and cRNA 
production for wt FPV and FPV NS VN. The GD and Ma NS segments affected both transcription and 
replication and enhanced the accumulation of viral mRNAs compared to that of wt FPV and FPV NS 
VN in infected cells. In addition, FPV NS Ma had a delayed peak of viral mRNA accumulation, 
suggesting that NS segments can influence the time course of RNA synthesis. Similar results were 
observed for both the NA and NP gene segments. In vitro RNP reconstitution experiments (Fig. 3C) 
indicated that the NS1 protein was likely to have an effect on viral RNA production, as an increase in 
the accumulation of cRNA amounts by GD NS, VN NS, and Ma NS was observed compared to that of 
FPV NS. However, during infection, GD and Ma NS viruses showed increased accumulation of viral 
mRNAs, suggesting that the effect of NS segments on the viral transcription and replication in infected 
cells may not be a direct effect and might depend on other viral factors.  
  
 
The IV polymerase can transcribe and replicate viral RNA in the absence of host factors (38), but it 
has also been shown that host factors may regulate or enhance viral RNA transcription and replication 
in infected cells (17, 35). Recently, the influenza A virus NS1 protein was reported to form a complex 
with CPSF-30 and the viral RNPs (20). Since CPSF-30 is present in both the infection and RNP 
reconstitution assays and our previous data showed that GD NS1 and FPV NS1 have similar binding 
affinities for the F2F3 domain of CPSF-30 (26), this interaction is unlikely to be responsible for the 
different effects observed during infection and RNP reconstitution.  
 
It has been suggested that the transiently expressed PR8 NS1 protein can enhance CAT reporter 
gene expression by increasing overall translation (47). Our in vitro RNP reconstitution experiments 
using a CAT reporter gene (see Fig. S3 in the supplemental material) showed that the NS1 effect on 
viral transcription and replication depends on the strain background of the viral RNP complex, because 
the PR8 NS1 protein enhanced CAT expression of only the PR8 RNP complex but not the FPV and 
GD systems. The observation that NS1 proteins can form complexes containing CPSF30 with only 
cognate RNP complexes rather than RNP complexes of other viral strains (20) further supports this 
conclusion.  
 
Although it is not clear how NS1 affects viral transcription and replication, we observed that all NS1 
proteins were exclusively located in the nuclei of transfected cells, while a proportion of the GD and 
Ma NS1 proteins in infected cells also resided in the cytoplasm (Fig. 4). It has been suggested that the 
NES of NS1 is masked by an adjacent inhibitory amino acid sequence in transfected cells, while it is 
unmasked during infection due to specific interaction with another viral protein (23). It is therefore 
possible that the GD and Ma NS1 protein can enhance RNA-dependent RNA polymerase (RdRp) 
replication and transcription activity during infection but have reduced activity in RNP reconstitution 
experiments due to nuclear retention resulting in a direct or indirect decrease of polymerase activity.  
 
Despite there being no obvious correlation of NS1 localization with infectious virus titers, the different 
localization patterns of the NS1 proteins during infection (Fig. 4) may be contributing to the effects we 
observed on virus replication and/or host immune responses. As the NS1 protein has diverse roles in 
both the cytoplasm and nuclei of infected cells, we cannot exclude the possibility that different 
localizations of the NS1 proteins studied may play a role in the downstream effects observed.  
 
The observation that more rapid RNP export correlated with higher virus titers (Fig. 5) indicates that 
less efficient RNP export leads to lower infectious titers by limiting RNPs available for packaging (42). 
NS2/NEP can mediate RNP export by interaction with the M1 protein. The amino acid comparison of 
NS2/NEP (see Fig. S4C in the supplemental material) shows that there are only two amino acid 
differences between the GD and Ma NS2/NEP protein sequences. Therefore, if NS2/NEP alone 
confers the demonstrated difference in RNP export, it should be based on this two-amino-acid 
difference. Even though it is unlikely that NS2/NEP is responsible for the observed differences, further 
investigation is needed.  
 
The NS1 protein is known to impair host immune responses. In this study, we show that NS segment 
exchange in an FPV background altered IFN-β production and that IFN-β levels were inversely 
correlated to the infectious virus titer (Fig. 6). It is also known that the NS1 protein is involved in the 
regulation of apoptosis; however, it is not clear whether it plays a pro- or antiapoptotic role (16). 
Nevertheless, in our experiments, we found that the levels of apoptosis induced were inversely 
correlated to the infectious virus titers (Fig. 7). IFN can make cells more sensitive to apoptosis (1), but 
it is still not clear how viral replication/transcription and the antiviral response are related.  
 
In an overall comparison of the different NS proteins, we found that the GD NS1 protein sequence is 
similar to that of Ma NS1, differing by only 8 aa (see Fig. S4B in the supplemental material). Notable 
differences are found at (i) position 41, which is reported to be important for dsRNA binding (9, 54), is 
part of NLS1 (31), and comprises an ISG15 acceptor site (56); (ii) position 166, which is implicated in 
the interaction with PI3K (49); and (iii) position 224, which is located in the PABII binding region (6) 
and is important for the nucleolar targeting function of the NS1 protein (31). The VN NS1 protein is 
truncated at the C terminus by 10 aa and also contains a 5-aa internal deletion (see Fig. S4B in the 
supplemental material). As a consequence of the C-terminal truncation, the VN NS1 protein lacks a 
PDZ domain (227 to 230 aa) and a PABII-binding region (223 to 230 aa). NS2/NEP amino acid 
sequences are more conserved than that of NS1 (see Fig. S4C in the supplemental material). The 
majority of differences are found between the two allele A and the two allele B segments. Interestingly, 
a single amino acid difference between FPV and VN NS2/NEP that is located at position 14 is in the 
  
nuclear export sequence (NES), which is suggested to be a Crm-1 binding site (37). All remaining 
differences are in uncharacterized regions. To which extent these differences contribute to the 
different viral characteristics is currently under investigation.  
 
The NS1 protein plays a very important and multifactorial role in the battle between IV and its host. 
Our results show that the exchange of NS segments can have a significant effect on the replication 
ability of the virus and supports the notion that the protein products of the NS segment are involved in 
many stages of the virus life cycle. Surprisingly, as shown here for the first time, this includes not only 
the inhibition of the host response and induction of apoptosis but also accumulation of viral RNAs and 
vRNP export. Presently, it is not possible to conclude which of these effects is the most important in 
determining the replication ability of viruses. The effects of different NS segments on the replication of 
reassortant viruses are likely to be due to multiple effects of the NS1 protein on multiple viral and host 
processes. 
 
Biosafety. All experiments with infectious virus were performed according to German regulations for 
the propagation of influenza A viruses. All experiments involving highly pathogenic influenza A viruses 
were performed in a biosafety level 3 (BSL3) containment laboratory approved for such use by the 
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Figure 1. Phenotype of foci, infectious titer, and HA titer of recombinant FPV viruses. (A) Focus assay 
showing plaque sizes. MDCK cell monolayers were infected with the different recombinant viruses at 
an MOI of 0.001 and stained using a monoclonal antibody against NP. (B) Distribution curve of the 
average diameters of foci. From each recombinant virus, 50 to 78 foci were measured. (C) Virus 
growth curves and HA titers at an MOI of 0.01. Virus growth curves (lines) were determined by focus 
assays in MDCK cells and measured in focus-forming units (FFU)/ml. HA titers (bars) were determined 
using 1.5% chicken red blood cells and measured in HA units/ml. Results represent the averages from 





















Figure 2. Comparison of the accumulation of viral RNA species during infection by an NA gene-
specific primer extension. (A) Primer extension analysis. MDCK cells were infected at an MOI of 1.0 
and total RNA was harvested at the time points indicated. 32P-labeled NA gene-specific primers were 
used in a reverse transcription reaction and the products were analyzed by PAGE (6 M urea). The 
results are the averages from three independent experiments. a.u., arbitrary units. (B) Quantification of 
the accumulation of mRNA species for each recombinant virus. RNA levels were normalized using the 
5S rRNA control, and results represent the averages from three independent experiments. Error bars 
represent standard deviations. (C) Quantification of the accumulation of cRNA species for each 






























Figure 3. Comparison of the accumulation of viral RNA species during RNP reconstitution by NA 
gene-specific primer extension. (A) Primer extension analysis. 293T cells were transfected with 
plasmids expressing the PB1, PB2, PA, and NP proteins of FPV and FPV NA vRNA. Either empty 
vector or plasmids encoding the various NS1 or NS2/NEP proteins were cotransfected into the cells. 
Total RNA was harvested after 48 hours and analyzed by NA gene-specific primer extension. (B) 
Quantification of RNA levels following expression of different NS2/NEP proteins. mRNA, cRNA, and 
vRNA levels were calculated from the results of three independent experiments and expressed as a 
percentage of the values in the presence of FPV NS2/NEP (which were set to 100%). (C) 
Quantification of RNA levels following expression of different NS1 proteins. mRNA, cRNA, and vRNA 
levels were calculated from the results of three independent experiments and expressed as a 
percentage of the values in the presence of FPV NS1 (which were set to 100%). (D) CAT assay 
testing the effect of the GD NS1 protein on CAT expression. 293T cells were transfected with plasmids 
expressing CAT at different concentrations (pcDNA3-CAT, 0.05 μg, 0.1 μg, 0.2 μg) and GD NS1 

























Figure 4. Immunofluorescence of NS1 protein localization. (A) MDCK cells were infected with 
recombinant viruses at an MOI of 0.1. At 4 h, 6 h, and 8 h p.i., the cells were fixed for 
immunofluorescence analysis. (B) MDCK cells were transfected with plasmids expressing the different 
NS1 proteins and fixed at 24 h posttransfection for immunofluorescence analysis. 
Immunofluorescence was carried out using antibodies against the NS1 protein (red) and DAPI (blue) 

































Figure 5. Recombinant viruses show differences in the nuclear export of RNPs. (A) 
Immunofluorescence showing RNP export of the different recombinant viruses. MDCK cells were 
infected with recombinant viruses at an MOI of 0.1, and at 8 h p.i. cells were stained with an anti-NP 
antibody (green) and DAPI (blue) for the nuclei. (B) Cell lysates of MDCK cells infected with the 
different viruses at an MOI of 1 were analyzed for ERK activation by Western blotting using a 
phosphospecific anti-ERK and an anti-ERK2 (control) monoclonal antibody. (C) Graph showing ERK 
activation by different recombinant viruses. MDCK cells were infected with recombinant viruses at an 
MOI of 1, and cell lysates were prepared at 4 h, 6 h, and 8 h p.i. Samples were analyzed for ERK 
activation by Western blotting using a phosphospecific anti-ERK and an anti-ERK2 (control) 
monoclonal antibody. The relative ERK activation values from two independent experiments were 







Figure 6. Recombinant viruses induce different levels of IFN-β. A549 cells were infected with the 
recombinant viruses at an MOI of 0.01. Supernatants were harvested at 24, 36, and 48 h p.i., and 















































Figure 7. Level of apoptosis induced by the recombinant viruses. (A) MDCK cells were infected with 
recombinant viruses (MOI of 1). Ten hours p.i., the cells were fixed and permeabilized before being 
processed using an in situ cell death detection kit (Roche) according to the manufacturer’s 
instructions. The specimens were then examined by confocal microscopy. Green dots represent 
apoptotic cells. The top panels were viewed using the laser channel alone, while the bottom panels 
were viewed using both light and the laser channel. (B) Quantification of the number of apoptotic cells. 
The number of green cells in five random views was counted in three independent experiments. (C) 
Relative caspase3 activity. MDCK cells were infected with recombinant viruses (MOI of 1). Eight hours 
p.i., the cells were analyzed for caspase3 activity. The results are based on averages from three 
independent experiments. 
 
 
 
 
  
